Navigation Links
Martek Announces Third Quarter 2008 Financial Results


Investing activities:

(Purchase) sale of investments and marketable

securities, net (10,850) 6,850

Expenditures for property, plant and equipment (5,587) (5,110)

Proceeds from sale of fluorescent detection

products business - 900

Repurchase from sale-leaseback transaction - (3,910)

Capitalization of intangible assets (3,208) (4,806)

Net cash used in investing activities (19,645) (6,076)

Financing activities:

Repayments of notes payable and other long-term

obligations, net (8,888) (759)

Repayments under revolving credit facility, net - (19,000)

Proceeds from stock option exercises and

other, net 7,243 2,209

Net cash used in financing activities (1,645) (17,550)

Net change in cash, cash equivalents 40,649 (2,103)

Cash and cash equivalents, beginning of period 16,973 15,578

Cash and cash equivalents, end of period $57,622 $13,475


Kyle Stults

Investor Relations

(410) 740-0081

SOURCE Martek Biosciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Martek to Announce Third Quarter 2007 Results on September 5, 2007
2. Martek to Present at Upcoming UBS Conference
3. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
4. Martek Announces Settlement of OmegaTech Milestone Litigation
5. Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge
6. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
7. Martek to Present at Upcoming ThinkEquity Partners Conference
8. Martek Announces Fourth Quarter and FY 2007 Financial Results
9. Martek Signs DHA/ARA License and Supply Agreement With IlDong Foodis for Infant Formula in South Korea
10. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
11. Challenge Spreadable Butter Now Features Marteks lifesDHA(TM)
Post Your Comments:
(Date:7/10/2014)... Mass. (PRWEB) July 10, 2014 Terascala, ... today announced that Alan Swahn, a former vice president ... executive team as vice president of marketing. Terascala’s software ... Dell and NetApp create the highest performance and most ... been appointed to guide Terascala’s channel expansion and broaden ...
(Date:7/10/2014)... Robert Harman, DVM, Founder and CEO of Vet-Stem, Inc., ... the relaunch of his highly informative blog, now named Stem ... What are Stem Cells ?” Dr. Harman’s purpose for ... the basics of stem cell therapy so that pet owners ... treatment when considering regenerative medicine. , A veterinarian by trade, ...
(Date:7/10/2014)... EvoDerma ’s NOOME Anti-Aging Motion has been upgraded ... with a second treatment cup to help prevent and smooth ... is thinner on the edges for a softer contact with ... uneven surfaces on the face, neck and décolleté. Choose to ... areas such as the cheeks and neck, or opt for ...
(Date:7/10/2014)... , July 10, 2014  Franciscan St. ... of capnography for respiratory monitoring outside the ... healthcare leaders in embracing state-of-the-art patient safety ... patients are breathing and can alert medical ... measuring the amount of carbon dioxide the ...
Breaking Biology Technology:Terascala Expands Executive Team 2Terascala Expands Executive Team 3Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2
... among stations to run 30-second spot on Pyratine XR(TM) and ... Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company ... of healthy aging, announced today that on June 27, 2009 ... XR(TM) (0.125% furfuryl tetrahydropyranyl adenine) and rosacea, a condition afflicting ...
... N.C., June 26 Syngenta Biotechnology, Inc. announced today ... and commercial license agreement for Chromatin,s proprietary gene stacking ... Chromatin has developed a novel approach to gene stacking, ... Under this agreement, Syngenta has obtained exclusive rights to ...
... EasyMax™ is a ... heating and cooling without an additional cryostat. For a limited time, METTLER TOLEDO is ... EasyMax™, and the chance to WIN A SKI WEEKEND* in St. Moritz, Switzerland or Colorado, ... Columbia, MD (PRWEB) ...
Cached Biology Technology:Television News Segment Featuring Pyratine XR to Air to 18 Million + Households on DIRECTV NewsCluster 2Syngenta Licenses Chromatin Gene Stacking Technology for Sugar Cane 2Syngenta Licenses Chromatin Gene Stacking Technology for Sugar Cane 3Register to Win a Ski Weekend and Make Your Synthesis Easier with EasyMax™: the First Automated Chemistry Development Tool That Requires No Training 2
(Date:7/11/2014)... available in German . ... that uses the refraction of X-rays through a specimen ... with this method are often of much higher quality ... team of Prof. Franz Pfeiffer are particularly interested in ... including X-ray phase-contrast imaging. One main goal is ...
(Date:7/11/2014)... Salk Institute for Biological Studies, BGI, and other ... and reliability of the existing targeted gene correction ... which could significantly increased gene-correction efficiency in human ... online in Cell Stell Cell provides ... therapy. , The combination of stem cells and ...
(Date:7/11/2014)... Researchers have pioneered a revolutionary new way to ... Virtual Finger, allows scientists to move through digital ... using the flat surface of their computer screens. ... orders of magnitude more efficient, saving time, money ... areas of experimental biology. The software and its ...
Breaking Biology News(10 mins):New simple setup for X-ray phase contrast 2A new genome editing method brings the possibility of gene therapies closer to reality 2Virtual finger enables scientists to navigate and analyze complex 3D images 2
... accumulation of genetic damage in our cells is a major ... published today in the journal Nature by an international group ... critical gene for repairing damaged DNA grow old rapidly and ... that grow old naturally. Furthermore, the premature aging symptoms of ...
... transplant (HSCT) recipients face a significant long-term risk for ... at the time of transplant or received stem cells ... Published in the January 1, 2007 issue of CANCER ... Cancer Society, the study reveals that within 10 years ...
... researchers have developed a biochip that measures the electrical activities ... data in just one reading than is possible with current ... speed scientific research, which could accelerate drug development for muscle ... crop varieties. , "Instead of doing one experiment ...
Cached Biology News:Buildup of damaged DNA in cells drives aging 2Buildup of damaged DNA in cells drives aging 3Buildup of damaged DNA in cells drives aging 4Long-term cancer risk follows stem cell transplant recipients 2New biochip helps study living cells, may speed drug development 2New biochip helps study living cells, may speed drug development 3
COMING SOON: Anti-Mouse C5a Receptor (CD88), Clone 10/92 Monoclonal Antibody...
... Rabbit polyclonal to SARA ( Abpromise ... Antigen: Synthetic peptide: PVPKEMEQPV QTEEEDVELP ... 281-300 of Fruit fly (Drosophila melanogaster) SARA. ... Entrez Gene ID: 9372 ...
Rabbit polyclonal to Bag5 ( Abpromise for all tested applications). entrezGeneID: 9529 SwissProtID: Q9UL15...
AADAC Immunogen: AADAC (NP_001077, 201 a.a. ~ 301 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Biology Products: